9EJS
Bruton's tyrosine kinase with mutations in the activation loop in complex with compound PTI52
これはPDB形式変換不可エントリーです。
9EJS の概要
| エントリーDOI | 10.2210/pdb9ejs/pdb |
| 関連するPDBエントリー | 9EJJ 9EJR |
| 分子名称 | Tyrosine-protein kinase BTK, 4-{4-amino-1-[(3R)-1-(cyclopropanecarbonyl)piperidin-3-yl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-N-(4-cyclopropylpyridin-2-yl)benzamide, DIMETHYL SULFOXIDE, ... (4 entities in total) |
| 機能のキーワード | inhibitor, kinase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
| 由来する生物種 | Mus musculus (house mouse) |
| タンパク質・核酸の鎖数 | 3 |
| 化学式量合計 | 97110.50 |
| 構造登録者 | Lin, D.Y.,Andreotti, A.H.,Tonge, P.J.,Bravo, E.,Li, X. (登録日: 2024-11-28, 公開日: 2025-08-13, 最終更新日: 2025-08-20) |
| 主引用文献 | Bravo Jr., E.,Li, Y.,Lin, D.Y.,Srinivasan, B.,Barone, M.,Li, S.X.,DelloRusso, F.,Rahiyanath, A.S.,Corrionero, A.,Alfonso, P.,Prendiville, N.,Kozakov, D.,Andreotti, A.H.,Tonge, P.J. Modulating the Binding Kinetics of Bruton's Tyrosine Kinase Inhibitors through Transition-State Effects. J.Am.Chem.Soc., 147:27876-27891, 2025 Cited by PubMed Abstract: Optimization exercises strive toward increasing the efficacy and selectivity of small molecules toward the target of interest while simultaneously phasing out design elements that lead to off-target interactions. Given the nonequilibrium nature of biological systems, greater reliance should be placed on engineering kinetic selectivity in addition to equilibrium thermodynamic selectivity; however, the rational design of kinetic selectivity is a challenging endeavor. This study presents a systematic knowledge-based approach to the design of inhibitors that vary in their binding kinetics for Bruton's tyrosine kinase (BTK), a target for treating B-cell malignancies and autoimmune diseases. A detailed kinetic assessment was performed on existing BTK inhibitors, which, together with structural studies, provided critical insights into BTK-inhibitor interactions that control the kinetics of enzyme inhibition. Subsequently, a series of pyrazolopyrimidines was designed with the objective of modifying interactions between the inhibitor and the regulatory (R) spine in the kinase back pocket, which were hypothesized to modulate the stability of the transition state on the binding reaction coordinate. This resulted in the development of BTK inhibitors with extended residence time in which the variation in and was uncoupled from equilibrium thermodynamic affinity. PubMed: 40726426DOI: 10.1021/jacs.5c07063 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.26 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






